Cell-surface glycoconjugates of normal epithelia are recognized to alter during ontogeny and oncogenesis [ 11. Such changes affcct intercellular contact and modify patterns of organ colonization during invasion and metastasis. A particularly common feature of epithelial malignancies is an increased sialyation of cell surface oligosaccharide determinants. In a study of primary and metastatic human breast canccr, Foster & Neville 121 identified a population of plasma membrane glycoproteins in which sialylation correlated with aberrant intracellular processing. Recently, Abel et al. [3] examined cloned tumours of the Dunning rat prostate cancer model. They demonstrated that specific differences in structure and intracellular expression of oligosaccharide determinants by phenotypically distinct clones of the tumours in vivo were both consistent and specific. In this model, sialylation of glycoprotein oligosaccharides appeared to be a common feature o f all the tumours examined. Although a valuable technique, immunohistochemistry of intact tissues does not provide adequate information about events and structures occurring on the surfaces of individual tumour cells. To obtain quantitative information about the expression of oligosaccharide determinants by individual tumour cells, we have employed fluorescence-activated cellsorting to analyse lectin binding by two phenotypically distinct tumours within the Dunning prostate cancer model.
Cell-surface glycoconjugates of normal epithelia are recognized to alter during ontogeny and oncogenesis [ 11. Such changes affcct intercellular contact and modify patterns of organ colonization during invasion and metastasis. A particularly common feature of epithelial malignancies is an increased sialyation of cell surface oligosaccharide determinants. In a study of primary and metastatic human breast canccr, Foster & Neville 121 identified a population of plasma membrane glycoproteins in which sialylation correlated with aberrant intracellular processing. Recently, Abel et al. [3] examined cloned tumours of the Dunning rat prostate cancer model. They demonstrated that specific differences in structure and intracellular expression of oligosaccharide determinants by phenotypically distinct clones of the tumours in vivo were both consistent and specific. 
634th MEETING. BATH 969 employed method was identical to that previously described 151. In a parallel study, identical aliquots of cells were incubated with 100 m-units of neuraminidase type III/ml ( Vihrio cholerue) in 10 mM-sodium-phosphate-buffered saline (pH 7.4) for I h at 37°C before being washed and stained with lectins, as for the previous aliquots. After washing t o remove unbound lectins, all cells were analysed with a Coulter EPICS Profile flow cytometer using a 15 mW lascr at 488 nm (excitation) analysed at 5 17 nm. The flow-cytomctric data of AT-2. land AT-3.1 cells analysed according t o cell-surface binding of fluoresceinconjugated lectins are presented in Table 1 . These data confirm that the majority of AT-2.1 and AT-3.1 cells elaborate both typc I and type I1 oligosaccharide structures. However, in both phenotypes, type I sequences (PNA :Gal/31 -+ 3Gal-NAc) were almost completely masked by sialic acid and only detected following desialylation. This structure was synthesized by a greater population of the low-metastatic AT-2. I cells (80.7%,, post-neuraminidase) than by the highly metastatic AT-3.1 cells (58.8%, post-neuraminidase). The mean fluorescence density/cell of type I structures was similar in AT-2.1 (38.7) and AT-3.1 (39.7). Although type I determinants were freely expressed o n a greater proportion of AT-2. I cells (8.6:0.9), these occurred at lower mean density/cell (6.8: 13.7). Type II sequences (ECG:Gal@I -. 4GlcNAc) were freely expressed at a higher mean density/cell and by a larger proportion of AT-2.1 (96.2%) than AT-3. I cells (84.5%). Desialylation confirmed this structure to be partially masked by sialic acid in both phenotypes. although synthesized by equivalent proportions of AT-2.1 (82.8%,, post-neuraminidase) and AT-3.1 cells (85"/0, post-neuraminidase). The unmasked density of expression was then similar in the two phenotypes (AT-2.1 : 34.7 and AT-3.1 :4 1.9). Binding of lectins which recognize sialic acids (LFA. LPA and SNA), together with the selective action of this specific ncuraminidasc from V. cholerue [6] , indicate that predominant typc o f sialic acid expressed by both tumour phenotypes t o be NeuSAc (N-acetylneuraminic acid) rather than NeuSGc (Nglycolylneuraminic acid j.
This study has confirmed selective sialylation of specific oligosaccharide structures t o be a characteristic feature o f both low-and high-metastatic cell lines within the Dunning rat prostatic carcinoma model. Differences in expression of non-sialylated and sialylated cell-surface oligosaccharide structures. although subtle, may be important in determining cell-cell recognition and binding to the extracellular matrix, thus influencing the metastatic potential of thcsc tumour cells.
We are grateful to Coulter Electronics Ltd. U.K. lor their invaluable advice and assistance with this project. lmmunoassay techniques using monoclonal antibodies t o keratan sulphate (KS) provide a sensitive tool for quantifying KS in cartilage and body fluids 1 1-31. However. recent studies have shown the quantification o f KS present in bovine cartilage t o be dependent on the structural prcsentation of the antigen 14-61. In the present study, we determined the influence of antigen presentation, typc of antibody, and choice of immunoassay o n the quantification of KS epitope in human articular and bovine nasal cartilage. Proteoglycan (PG) monomer (A1 D I ) from human articular and bovine nasal cartilage was digested with chondroitinase ABC, yielding a KS-bearing PG core protein (PG-core). Smaller KS-containing pcptidcs were further prepared by ( a ) digestion o f PG-core with trypsin and purification o n DEAE-Sephacel (KS peptide I ) , and ( h ) digestion of KS-peptidc 1 with papain (KS-peptide 2). Gelfiltration chromatography was performed on a Sepharose CL-6B column eluted with 2 M-guanidine HCI. Total sulphated glycosaminoglycans (S-GAG) were determined using the I ,9-Dimethylmethylene Blue dye-binding assay [ 71.
Abbreviations used: KS. kcratan sulphate; PG. proteoglycan; P<;-core. PG core protein: S-GAG, sulphated glycosaminoglyenn; KIA. radioimmiinoass~iy; ELISA. enzyme-linked immunosorbent ass;ly.
Quantification of KS epitope was performed by both competitive inhibition radioimmunoassay (RIA), and noncompetitive inhibition enzymc-linked immunosorbent assay (ELISA). Gel-filtration chromatography, and analysis of thc fractions for total S-GAG content showed the PG-core preparation of human articular cartilage to elute at and close to the void volume ( V,,) of the column. In contrast, the elution profile for KS-peptide 1 revealed a broad bimodal peak included in the column. whereas KS-peptide 2 eluted as ;I single peak close t o the total volume ( V,) (Fig. 1) . However, analyses o f the same fractions by RIA and ELISA (using the anti-KS antibodies 12.1. 5-D-4 and MZ1 5) consistently demonstrated KS epitope t o elute only in the high M , fractions o f the preparations tested (Fig. I ) . Similar results were obtained with preparations from bovine nasal cartilage.
lmmunochemical determination of KS in preparations of human and bovine protcoglycan fragments showed a progressive loss of apparent KS epitope per unit of S-GAG with a reduction in size of the fragments. Larger proteoglycan fragments containing multiple KS-chains displayed a higher inhibitory capacity than KS-bearing fragments of lower M,. The magnitude of this change was dependent o n the immunoassay and on the antibody used. Thus, the inhibi-
